Log In
BCIQ
Print this Print this
 

Simplexa Group A Strep Direct

  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
DescriptionReal time-PCR assay for in vitro qualitative detection of group A Streptococcus DNA from throat swabs
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect group A Streptococcus bacteria from throat swabs
Regulatory Designation
Partner3M Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$300.0M

$300.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/30/2016

$300.0M

$300.0M

0

Get a free BioCentury trial today